Garry R. Smith

1.4k citations

37 papers · 858 indexed · h-index 16

Organic Chemistry top 5%
Molecular Biology
Cellular and Molecular Neuroscience top 10%
Materials Chemistry
Toxicology top 2%

Co-authors: Allen B. Reitz Arpad Z. Szarka Robin M. Hochstrasser Roseanne J. Sension Michael H. Parker Scott M. Rawls Harold G. Selnick Andrew J. Tebben
Topics: Chemical Synthesis and Analysis (7 papers)Neurotransmitter Receptor Influence on Behavior (6 papers)Carbohydrate Chemistry and Synthesis (6 papers)
Cited by: Toxicology Organic Chemistry Cellular and Molecular Neuroscience
Journals: Circulation Journal of Medicinal Chemistry Chemical Physics Letters
Partner nations: United States Netherlands France

In The Last Decade

Garry R. Smith

37 papers receiving 832 citations

Peers

Countries citing papers authored by Garry R. Smith

Since Specialization

Citations

This map shows the geographic impact of Garry R. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry R. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry R. Smith more than expected).

Fields of papers citing papers by Garry R. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry R. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry R. Smith. The network helps show where Garry R. Smith may publish in the future.

Co-authorship network of co-authors of Garry R. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Garry R. Smith. A scholar is included among the top collaborators of Garry R. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry R. Smith. Garry R. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemokines and ‘bath salts’: CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats 2018 ·Drug and Alcohol Dependence ·Chicora F. Oliver,Steven J. Simmons,(unknown),Garry R. Smith,Allen B. Reitz,Scott M. Rawls	19
2	Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG) 2017 ·Psychopharmacology ·Callum Hicks,Ryan A. Gregg,(unknown),Lee Anne Cannella,(unknown),Christopher S. Tallarida,Allen B. Reitz,Garry R. Smith,Scott M. Rawls	20
3	Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator 2016 ·Neuropharmacology ·Ryan A. Gregg,Callum Hicks,(unknown),Christopher S. Tallarida,(unknown),Garry R. Smith,Allen B. Reitz,Scott M. Rawls	28
4	High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor Chemotypes 2016 ·ACS Combinatorial Science ·Kristin M. Bompiani,Dejan Caglič,(unknown),(unknown),(unknown),Luke L. Lairson,(unknown),Garry R. Smith,Tobin J. Dickerson	2
5	Synthesis of lemonose derivatives: methyl 4-amino-3-O,4-N-carbonyl-2,4,6-trideoxy-3-C-methyl-α-l-lyxo-pyranoside and its phenyl thioglycoside 2015 ·Carbohydrate Research ·(unknown),(unknown),Garry R. Smith,(unknown),Walter J. Boyko,Nicholas A. Piro,W. Scott Kassel,Robert M. Giuliano	6
6	Stereochemistry and neuropharmacology of a ‘bath salt’ cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates 2014 ·Neuropharmacology ·(unknown),Ryan A. Gregg,(unknown),(unknown),(unknown),Christopher S. Tallarida,(unknown),Robert B. Raffa,Garry R. Smith,Allen B. Reitz,Scott M. Rawls	18
7	Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Mark E. McDonnell,(unknown),Jay Wrobel,Garry R. Smith,Shuguang Liang,Haiching Ma,Allen B. Reitz	15
8	Small-Molecule Anticonvulsant Agents with Potent In Vitro Neuroprotection and Favorable Drug-Like Properties 2013 ·Journal of Molecular Neuroscience ·Garry R. Smith,Douglas E. Brenneman,Yan Zhang,Yanming Du,Allen B. Reitz	6
9	Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: Extending towards the β-exosite 2012 ·Bioorganic & Medicinal Chemistry Letters ·Garry R. Smith,Dejan Caglič,Petr Čapek,Yan Zhang,(unknown),Allen B. Reitz,Tobin J. Dickerson	12
10	Small Molecule Anticonvulsant Agents with Potent In Vitro Neuroprotection 2012 ·Journal of Molecular Neuroscience ·Douglas E. Brenneman,Garry R. Smith,Yan Zhang,Yanming Du,(unknown),Michael J. Zdilla,Allen B. Reitz	8
11	Riluzole prodrugs for melanoma and ALS: Design, synthesis, and in vitro metabolic profiling 2012 ·Bioorganic & Medicinal Chemistry ·Mark E. McDonnell,Matthew D. Vera,Benjamin E. Blass,Jeffrey C. Pelletier,Richard C. King,Carmen Fernández‐Metzler,Garry R. Smith,Jay Wrobel,Suzie Chen,B. Wall,Allen B. Reitz	24
12	The role of sulfamide derivatives in medicinal chemistry: a patent review (2006 – 2008) 2009 ·Expert Opinion on Therapeutic Patents ·Allen B. Reitz,Garry R. Smith,Michael H. Parker	67
13	In Vivo Canine Cardiac Electrophysiologic Profile of 1,4-Benzodiazepine Iks Blockers 2003 ·Journal of Cardiovascular Pharmacology ·Gary L. Stump,Garry R. Smith,Andrew J. Tebben,(unknown),Joseph J. Salata,Harold G. Selnick,David A. Claremon,Joseph J. Lynch	15
14	Synthesis of methyl α-l-vancosaminide 1999 ·Carbohydrate Research ·Garry R. Smith,Robert M. Giuliano	6
15	An Improved Procedure for the Cyanation of Aryl Triflates: A Convenient Synthesis of 6-Cyano-1,2,3,4-Tetrahydroisoquinoline 1995 ·Synthetic Communications ·Harold G. Selnick,Garry R. Smith,Andrew J. Tebben	35
16	Carbohydrate N-phosphinyl imine derivatives: synthesis and conversion to amino sugars 1995 ·Carbohydrate Research ·Robert M. Giuliano,(unknown),Garry R. Smith	2
17	O-Phosphohydroxylysinuria: a new inborn error of metabolism? 1990 ·Clinica Chimica Acta ·L. Dorland,M. Durán,P.K. De Bree,Garry R. Smith,(unknown),(unknown),S.K. Wadman	4
18	Syntheses from phthalimido-acids. Part V. Amides of glycine, DL-alanine, and L-glutamic acid with amphetamine, benzocaine, and procaine 1954 ·Journal of the Chemical Society (Resumed) ·F. E. King,JW Clark-Lewis,Garry R. Smith	2
19	Syntheses from phthalimido-acids. Part VI. Further products from phthalyl-DL-aspartic anhydride, and the preparation of phthalylglycyl-DL-asparagine and -DL-serine 1954 ·Journal of the Chemical Society (Resumed) ·F. E. King,JW Clark-Lewis,Garry R. Smith	2
20	Syntheses from phthalimido-acids. Part IV. p-Glycylaminobenzoic acid and derivatives 1954 ·Journal of the Chemical Society (Resumed) ·F. E. King,JW Clark-Lewis,(unknown),Garry R. Smith	9

About Garry R. Smith

Garry R. Smith is a scholar working on Toxicology, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 37 papers that have together received 858 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Carbohydrate Chemistry and Synthesis (6 papers). The work is most often cited by research in Toxicology (113 citations), Organic Chemistry (373 citations) and Cellular and Molecular Neuroscience (146 citations). Garry R. Smith has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Allen B. Reitz, Arpad Z. Szarka, Robin M. Hochstrasser, Roseanne J. Sension, Michael H. Parker, Scott M. Rawls, Harold G. Selnick, Andrew J. Tebben, Christopher S. Tallarida and Ryan A. Gregg. Their work appears in journals such as Circulation, Journal of Medicinal Chemistry and Chemical Physics Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact